Дарниця розширює географію експортних ринків

First, the market is recovering, and the industry is gaining momentum in the second year of the major war. Thus, sales of medicines in the first half of 2023 increased…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…